Table 3.
Clinical characteristics between non-fever and fever groups of the training cohort.
| Variables | All subjects (N = 877) | Non-fever (N = 716) | Fever (N = 161) | p value |
|---|---|---|---|---|
| Sex (n [%]) | 0.091 | |||
| Male | 507 (57.8) | 424 (59.2) | 83 (51.6) | |
| Female | 370 (42.2) | 292 (40.8) | 78 (48.4) | |
| Age (years), median (IQR) | 54.0 (46.0–64.0) | 54.0 (46.0–64.0) | 57.0 (50.0–66.0) | 0.023* |
| Age > 50 years (n [%]) | 541 (61.7) | 424 (59.2) | 117 (72.7) | 0.002* |
| Medication history (n [%]) | ||||
| Use of Antithrombotics | 26 (3.0) | 20 (2.8) | 6 (3.7) | 0.709 |
| Use of Immunosuppressants | 1 (0.1) | 0 (0.0) | 1 (0.6) | 0.413 |
| Use of NSAIDs | 3 (0.3) | 2 (0.3) | 1 (0.6) | 1.000 |
| Comorbidity (n [%]) | ||||
| Hypertension | 155 (17.7) | 125 (17.5) | 30 (18.6) | 0.811 |
| Diabetes mellitus | 33 (3.8) | 25 (3.5) | 8 (5.0) | 0.509 |
| History of malignancy | 46 (5.2) | 39 (5.4) | 7 (4.3) | 0.712 |
| History of abdominal operation | 97 (11.1) | 82 (11.5) | 15 (9.3) | 0.521 |
| History of intestinal polyp removal | 27 (3.1) | 25 (3.5) | 2 (1.2) | 0.215 |
IQR, interquartile range; NSAIDs, Non-Steroidal Anti-Inflammatory Drugs. *P-value < 0.05.